Roger Schibli, Head of Center for Radiopharmaceutical Sciences at PSI Paul Scherrer Institut will share his insights on RLT a vision for the future and what’s next in RLT.
Ivana Galetic, SVP Program Management at ARTBIO will talk about Developing RLTs and the challenges and opportunities.
Jeevan Virk, Radioligand Therapy (RLT) Leadership at Novartis will speak about bringing RLT to patients including capacity, logistics and positioning.
Julia Hepp, VP Partnering & Alliances and Michael Pitzner, General Counsel, Senior Vice President Legal and Business Development, both from Molecular Partners will exchange on partnering for RLTs and the BD Landscape.
Don’t miss the chance to connect with industry professionals during our networking apero afterwards.
The event will take place at the Novartis Pavillon, November 28th from 5:30pm - 9:00pm
Registration begins at 5:30 PM — reserve your spot today!
Swiss HLG, PLCF & Italy HLG invites you to join us for this timely webinar on the 7th November from 14:30 -16:00 CET.
STRATEGIC COMMERCIALIZATION OPTIONS IN EUROPE FOR MID SIZED HEALTHCARE COMPANIES
Ronald Van Zitteren, Principal at AIM will discuss the challenges faced by New Market Entrants in launching their products in Europe and Francois-Xavier CAPELO, VP International, Bioprojet will talk about Bioprojet’s orphan drug launch in Europe.
These two sessions will be followed by a live Q&A moderated by Bruno Delie, General Manager, Luye Pharma EU.
We are delighted to reveal that the IPLS, the umbrella organisation for all PLG/HLG groups across Europe and Canada, is launching a new IPLS Community Platform, to replace the previous IPLS database.
This is a unique resource that will enable Swiss HLG members to reach out to fellow members, as well as members of other IPLS national groups such as the UK PLG. It is a completely private platform with exciting modern functionality, including a newsfeed and discussion forums. Access to the platform is a significant benefit of Swiss HLG membership. Together with the UK PLG, we are pioneers in adopting the new system and other groups will come on board over the summer. The official launch will be at the IPLS conference on September 16-18 in Malaga.
Swiss HLG President chairing panel 'AI Transforming BioPharma Panel: Beyond the Hype', September 25th, 2024
Discover the Real Impact of AI in Biopharma! Join us for the 'AI Transforming BioPharma Panel: Beyond the Hype' at the hashtag#Sachs_BEF on September 25th, 2024, at the Mövenpick Hotel Basel. Explore the genuine advancements and practical applications of artificial intelligence that are revolutionizing biopharmaceuticals.
This panel will cut through the noise to examine how AI technologies are truly transforming drug discovery, development, and market strategies. Engage with industry experts as they discuss overcoming challenges, achieving breakthroughs, and forecasting the future of AI in biopharma.
Don’t miss this opportunity to gain in-depth insights and network with pioneers in the field. Secure your spot today at www.sachsforum.com/24bef and join us, both hashtag#InPerson & hashtag#Online, during the Sachs Autumn Life Sciences Week.
Swiss HLG President chairing panel 'Latest Trends in Dealmaking for Bio-Pharma Panel' - September 26th, 2024, SACHS_BEF
Panellists: Alessandra Polara, Senior Director, Global BD, F. Hoffmann-La Roche AG Berthold Hinzen, Global Head BD&L Transactions Immunology, Novartis AG Jeremy Griggs, Executive Director, Business Development, GSK Richard Ward, Executive Director, Search & Evaluation, AstraZeneca
This panel offers a deep dive into the evolving landscape of dealmaking in the biopharma industry. Learn from top executives and dealmakers as they explore the latest trends, strategies, and challenges in mergers, acquisitions, and strategic partnerships. Gain insights into how these dynamics are shaping the industry and what it means for future innovation and growth.
Don’t miss this chance to enhance your strategic decision-making and networking capabilities. Secure your spot today at www.sachsforum.com/24bef and join us, both hashtag#inperson & hashtag#online, during the Sachs Autumn Life Sciences Week.
Swiss HLG Romandie Networking Event
Swiss HLG Romandie Networking Event
We have some exciting news: Join is for our annual after work networking event in Swiss Romandie in collaboration with Biopôle Lausanne and BioAlps - Swiss Health Valley on October 3rd at Biopôle in Lausanne.
There will be a panel presentation on Negotiations: Aligning stakeholders for success and a discussion with representatives from start-up, academia, pharma and venture capital followed by a networking apero.
Speakers:
Raluca Flükiger, Licensing officer at University of Geneva/Unitec
Vincent Ossipow, Partner at Omega Funds
Sergio Capancioni, Ph.D., Director Search & Evaluation International, AbbVie
Madiha Derouazi, CSO AC immune/Biotech entrepreneur
The Swiss HLG 23rd annual conference will be held on 25th - 27th May 2025 once again at the historic Belle Epoque Grand Hotel Suisse Majestic in the beautiful scenic location of Montreux, Switzerland.
Swiss HLG Start-Up Initiative workshop on June 12
We held the second Swiss HLG Start-Up Initiative workshop on June 12, kindly hosted by Johnson & Johnson at their new campus in Allschwil.
This initiative is a collaboration between Swiss HLG, BaseLaunch and Johnson & Johnson and aims to help 30 great biotech start-ups get Fit for Partnering through a series of four linked workshops.
It was a fantastic event with a great atmosphere and we are keenly looking forward to the next workshop in September, which will dive into partnering and term sheet negotiations.
